A new publication from our group, continuation of a paper published earlier this year (https://t.co/wxGlAOHUoA) showing how LE developed in subgroups with disease. Here we quantify how changes in survival and prevalence from the diseases contributed to the
RT @melb4886: Even more interesting in the light of COVID19 epidemic. https://t.co/MM5eeFMY7d
Even more interesting in the light of COVID19 epidemic.
Life expectancy gains for many with comorbidities vs general population. Not the case for those with #hipfracture where the life expectancy gap vs. the general population is growing. https://t.co/rj8uemHUSW